Concert Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced its virtual participation at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022. The live presentation will start at 7:00 a.m. ET and will be accessible via the Investors section of Concert's website. A replay of the webcast will be available for two weeks post-event. Concert is recognized for its late-stage development of CTP-543, a novel oral JAK1/2 inhibitor, targeting alopecia areata and other indications.

LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate virtually at the H.C. Wainwright 24th Annual Global Investment Conference, and its presentation will be available beginning at 7:00 a.m. ET on September 12, 2022.

The on-demand webcast of the presentation may be accessed in the Investors section of the Company’s website at www.concertpharma.com. A replay of the webcast will be available on Concert’s website for two weeks following the presentation.

About Concert

Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a novel oral JAK1/2 inhibitor. Concert has successfully completed two Phase 3 trials with CTP-543 in adults with alopecia areata, a serious autoimmune dermatological condition. The Company is also evaluating the use of CTP-543 in other indications and assessing a number of earlier-stage pipeline candidates. For more information, please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005117/en/

Justine Koenigsberg

(781) 674-5284

ir@concertpharma.com

Source: Concert Pharmaceuticals, Inc.

FAQ

What event is Concert Pharmaceuticals participating in on September 12, 2022?

Concert Pharmaceuticals is participating in the H.C. Wainwright 24th Annual Global Investment Conference.

What time will Concert Pharmaceuticals' presentation start at the conference?

The presentation will start at 7:00 a.m. ET.

Where can I access the webcast of Concert Pharmaceuticals' presentation?

The webcast can be accessed in the Investors section of Concert's website.

How long will the replay of the webcast be available after the presentation?

The replay will be available for two weeks following the presentation.

What is CTP-543, developed by Concert Pharmaceuticals?

CTP-543 is a novel oral JAK1/2 inhibitor targeting alopecia areata.